Interleukin-2 shapes the cytotoxic T cell proteome and immune environment–sensing programs
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-2 shapes the cytotoxic T cell proteome and immune environment–sensing programs
Authors
Keywords
-
Journal
Science Signaling
Volume 11, Issue 526, Pages eaap8112
Publisher
American Association for the Advancement of Science (AAAS)
Online
2018-04-18
DOI
10.1126/scisignal.aap8112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche
- (2016) David Clever et al. CELL
- L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
- (2016) Roger Geiger et al. CELL
- Phosphoproteomic Analyses of Interleukin 2 Signaling Reveal Integrated JAK Kinase-Dependent and -Independent Networks in CD8 + T Cells
- (2016) Sarah H. Ross et al. IMMUNITY
- Extended-Release Once-Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate-Release Tofacitinib and Impact of Food
- (2016) Manisha Lamba et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy
- (2016) Mahima Swamy et al. NATURE IMMUNOLOGY
- The MaxQuant computational platform for mass spectrometry-based shotgun proteomics
- (2016) Stefka Tyanova et al. Nature Protocols
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- Single cell tuning of Myc expression by antigen receptor signal strength and interleukin-2 in T lymphocytes
- (2015) G. C. Preston et al. EMBO JOURNAL
- Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms
- (2015) Jamie B. Spangler et al. IMMUNITY
- Interleukin-2 Activity Can Be Fine Tuned with Engineered Receptor Signaling Clamps
- (2015) Suman Mitra et al. IMMUNITY
- The cytotoxic T cell proteome and its shaping by the kinase mTOR
- (2015) Jens L Hukelmann et al. NATURE IMMUNOLOGY
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Interleukin-2: Biology, Design and Application
- (2015) Natalia Arenas-Ramirez et al. TRENDS IN IMMUNOLOGY
- NFIL3 Orchestrates the Emergence of Common Helper Innate Lymphoid Cell Precursors
- (2015) Wei Xu et al. Cell Reports
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- A “Proteomic Ruler” for Protein Copy Number and Concentration Estimation without Spike-in Standards
- (2014) Jacek R. Wiśniewski et al. MOLECULAR & CELLULAR PROTEOMICS
- Survival factor NFIL3 restricts FOXO-induced gene expression in cancer
- (2013) M. Keniry et al. GENES & DEVELOPMENT
- Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
- (2013) Wei Liao et al. IMMUNITY
- Differentiation of CD8 memory T cells depends on Foxo1
- (2013) Rodrigo Hess Michelini et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen
- (2013) Andrew L Doedens et al. NATURE IMMUNOLOGY
- Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation
- (2013) Linda V Sinclair et al. NATURE IMMUNOLOGY
- Regulation of Immune Responses by mTOR
- (2012) Jonathan D. Powell et al. Annual Review of Immunology
- PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+T cells
- (2012) David K. Finlay et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation
- (2011) Wei Liao et al. CURRENT OPINION IN IMMUNOLOGY
- Protein Kinase B Controls Transcriptional Programs that Direct Cytotoxic T Cell Fate but Is Dispensable for T Cell Metabolism
- (2011) Andrew N. Macintyre et al. IMMUNITY
- T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells
- (2011) Guoyan Cheng et al. IMMUNOLOGICAL REVIEWS
- The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4+ T cells
- (2011) Yasutaka Motomura et al. NATURE IMMUNOLOGY
- The synapse and cytolytic machinery of cytotoxic T cells
- (2010) Misty R Jenkins et al. CURRENT OPINION IN IMMUNOLOGY
- Prolonged Interleukin-2Rα Expression on Virus-Specific CD8+ T Cells Favors Terminal-Effector Differentiation In Vivo
- (2010) Vandana Kalia et al. IMMUNITY
- Interleukin-2 and Inflammation Induce Distinct Transcriptional Programs that Promote the Differentiation of Effector Cytolytic T Cells
- (2010) Matthew E. Pipkin et al. IMMUNITY
- Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity
- (2010) Thomas R. Malek et al. IMMUNITY
- Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes
- (2009) David K. Finlay et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development
- (2009) Duncan M Gascoyne et al. NATURE IMMUNOLOGY
- CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses
- (2009) J. J. Obar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking
- (2008) Linda V Sinclair et al. NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now